The limitations of cytomegalovirus screening [3]

Prenatal Diagnosis

Volumn 26, Issue 9, 2006, Pages 869-870

  Zafar, U ^a   Ong, S ^b   Gray, J ^b   Martin, W M ^b   Kilby, M D ^b  

^a RUSSELLS HALL HOSPITAL   (United Kingdom)

^b BIRMINGHAM WOMEN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CASE REPORT; CLINICAL FEATURE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; FEMALE; HUMAN; LETTER; MORBIDITY; MORTALITY; PRIORITY JOURNAL; SEROLOGY; ULTRASOUND;

CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME;

CYTOMEGALOVIRUS;

EID: 33749459230     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.1514     Document Type: Letter

References (4)

1. Abdel-Fattah SA, Bhat A, Illanes S, Bartha JL, Carrington D. 2005. TORCH test for fetal medicine indication. Prenat Diagn 25(11): 1028-1031.
2. Cullen A, Brown S, Cafferkey M, O'Brien N, Griffin E. 1998. Current use of TORCH screen in the diagnosis of congenital infection. J Infect 36(2): 185-188.
3. Daiminger A, Bader U, Enders G. 2005. Pre- and periconceptional CMV infection: risk of vertical transmission and congenital disease. Br J Obstet Gynaecol 112(2): 166-172.
4. Guerra B, Lazzarotto T, Lanari M, Bovicelli L, Nicolosi A, Landini MP. 2000. Prenatal diagnosis of symptomatic congenital cytomegalovirus infection. Am J Obstet Gynecol 183(2): 476-482.